Reports Q4 revenue $5.07B, consensus $5.17B. “2024 was an outstanding year for Tenet characterized by robust revenue growth, efficient operations, high levels of patient satisfaction and clinical quality, and a portfolio transformation that drove substantial balance sheet deleveraging,” said Saum Sutaria, Chairman and CEO of Tenet. “Our focused strategy, disciplined operating management, and the strong demand for acute care and ambulatory surgical services provide us with momentum as we begin the year and confidence to achieve our full year 2025 expectations.”
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Notable companies reporting before Monday’s open
- Is THC a Buy, Before Earnings?
- Trump Trade: President advocates to close carried interest tax loophole
- White House readying order to fire thousands of federal health workers, WSJ says
- Tenet Healthcare Updates CEO Compensation Agreement